Procaps Group SA
NASDAQ:PROC

Watchlist Manager
Procaps Group SA Logo
Procaps Group SA
NASDAQ:PROC
Watchlist
Price: 1.1 USD
Market Cap: 124.1m USD

Net Margin
Procaps Group SA

12.6%
Current
12%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.6%
=
Net Income
52.2m
/
Revenue
414.2m

Net Margin Across Competitors

No Stocks Found

Procaps Group SA
Glance View

Market Cap
124.1m USD
Industry
Pharmaceuticals

Procaps Group SA develops pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. The firm develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. The company operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

PROC Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.6%
=
Net Income
52.2m
/
Revenue
414.2m
What is the Net Margin of Procaps Group SA?

Based on Procaps Group SA's most recent financial statements, the company has Net Margin of 12.6%.

Back to Top